NCT06895733 2025-03-26Study of Pazopanib Combined With Palbociclib for Refractory Solid Tumors With Co-amplified in the 11q13(FGF3/4/19/CCND1)Tianjin Medical University Second HospitalPhase 1/2 Recruiting65 enrolled